| Product Code: ETC9953351 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market - Industry Life Cycle |
3.4 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market - Porter's Five Forces |
3.5 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Specimen, 2021 & 2031F |
3.8 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Nucleic Acid and other Biomolecules, 2021 & 2031F |
3.9 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.10 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of rare diseases in the UK |
4.2.2 Growing demand for personalized medicine and targeted therapies |
4.2.3 Advancements in biomarker research and diagnostics |
4.3 Market Restraints |
4.3.1 High costs associated with rare biomarkers specimen collection and stabilization |
4.3.2 Limited awareness among healthcare professionals and patients about the importance of rare biomarkers |
4.3.3 Regulatory challenges related to the collection and handling of rare biomarkers |
5 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Trends |
6 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market, By Types |
6.1 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Circulating Cell Free DNA (ccfDNA), 2021- 2031F |
6.1.4 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Circulating Tumor Cells (CTCs), 2021- 2031F |
6.1.5 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Exosomes/Extracellular Vesicles, 2021- 2031F |
6.2 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Isolation Kits and Reagents, 2021- 2031F |
6.2.3 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Blood Collection Tubes, 2021- 2031F |
6.2.4 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Systems, 2021- 2031F |
6.3 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market, By Specimen |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Serum/Plasma, 2021- 2031F |
6.3.3 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market, By Nucleic Acid and other Biomolecules |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By RNA, 2021- 2031F |
6.4.3 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By DNA, 2021- 2031F |
6.4.4 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market, By Application |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By NIPT, 2021- 2031F |
6.5.3 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Oncology, 2021- 2031F |
6.5.4 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Transcriptomics, 2021- 2031F |
6.5.5 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Pharmacogenomics, 2021- 2031F |
6.5.6 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Transplant Rejection, 2021- 2031F |
6.5.7 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Population Screening, 2021- 2031F |
6.5.8 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Others, 2021- 2031F |
6.6 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market, By End use |
6.6.1 Overview and Analysis |
6.6.2 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Perinatal Clinics, 2021- 2031F |
6.6.4 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Public Health Labs, 2021- 2031F |
6.6.5 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Private or Commercial Labs, 2021- 2031F |
6.6.6 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Physician Labs, 2021- 2031F |
6.6.7 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Research Institutes, 2021- 2031F |
7 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Export to Major Countries |
7.2 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Imports from Major Countries |
8 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Key Performance Indicators |
8.1 Adoption rate of rare biomarkers specimen collection and stabilization technologies in UK healthcare facilities |
8.2 Research and development investments in rare biomarkers by pharmaceutical and biotechnology companies in the UK |
8.3 Number of clinical trials incorporating rare biomarkers in the UK |
8.4 Rate of successful biomarker identification and validation in the UK biomarker research sector |
9 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market - Opportunity Assessment |
9.1 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Specimen, 2021 & 2031F |
9.4 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Nucleic Acid and other Biomolecules, 2021 & 2031F |
9.5 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Application, 2021 & 2031F |
9.6 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By End use, 2021 & 2031F |
10 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market - Competitive Landscape |
10.1 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Rare Biomarkers Specimen Collection and Stabilization Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here